First Time Loading...

Venus Medtech Hangzhou Inc
HKEX:2500

Watchlist Manager
Venus Medtech Hangzhou Inc Logo
Venus Medtech Hangzhou Inc
HKEX:2500
Watchlist
Price: 5.62 HKD Market Closed
Updated: May 17, 2024

Gross Margin
Venus Medtech Hangzhou Inc

79.2%
Current
78%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.2%
=
Gross Profit
389.2m
/
Revenue
491.4m

Gross Margin Across Competitors

Country Company Market Cap Gross
Margin
CN
Venus Medtech Hangzhou Inc
HKEX:2500
2.5B HKD
79%
US
Abbott Laboratories
NYSE:ABT
181.1B USD
55%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.1B USD
66%
US
Stryker Corp
NYSE:SYK
127.5B USD
64%
IE
Medtronic PLC
NYSE:MDT
114.2B USD
66%
US
Boston Scientific Corp
NYSE:BSX
109B USD
69%
US
Becton Dickinson and Co
NYSE:BDX
68.2B USD
41%
DE
Siemens Healthineers AG
XETRA:SHL
59B EUR
36%
US
Edwards Lifesciences Corp
NYSE:EW
53.6B USD
77%
US
Dexcom Inc
NASDAQ:DXCM
51.9B USD
63%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
373.7B CNY
65%
Venus Medtech Hangzhou Inc
HKEX:2500
Country CN
Market Cap 2.5B HKD
Gross Margin
79%
Abbott Laboratories
NYSE:ABT
Country US
Market Cap 181.1B USD
Gross Margin
55%
Intuitive Surgical Inc
NASDAQ:ISRG
Country US
Market Cap 141.1B USD
Gross Margin
66%
Stryker Corp
NYSE:SYK
Country US
Market Cap 127.5B USD
Gross Margin
64%
Medtronic PLC
NYSE:MDT
Country IE
Market Cap 114.2B USD
Gross Margin
66%
Boston Scientific Corp
NYSE:BSX
Country US
Market Cap 109B USD
Gross Margin
69%
Becton Dickinson and Co
NYSE:BDX
Country US
Market Cap 68.2B USD
Gross Margin
41%
Siemens Healthineers AG
XETRA:SHL
Country DE
Market Cap 59B EUR
Gross Margin
36%
Edwards Lifesciences Corp
NYSE:EW
Country US
Market Cap 53.6B USD
Gross Margin
77%
Dexcom Inc
NASDAQ:DXCM
Country US
Market Cap 51.9B USD
Gross Margin
63%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Country CN
Market Cap 373.7B CNY
Gross Margin
65%

Profitability Report

View the profitability report to see the full profitability analysis for Venus Medtech Hangzhou Inc.

Full Profitability Report

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.2%
=
Gross Profit
389.2m
/
Revenue
491.4m
What is the Gross Margin of Venus Medtech Hangzhou Inc?

Based on Venus Medtech Hangzhou Inc's most recent financial statements, the company has Gross Margin of 79.2%.

ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.